Jan 1, 2025
Happy New Year 2025
Happy New Year May this year bring, joy, peace, and hope.
Resources
Dec 24, 2024
Happy Holidays
Happy Holidays from everyone at the Macular Degeneration Association. As the year ends, we thank you for your never-ending support. New research & treatments are transforming the landscape for…
Dec 23, 2024
First of its kind study lists health benefits of drinking more water each day
Published December 18, 2024 | Originally published on ScienceAlert Latest We all know that staying hydrated is good for human health – but a new study goes into more specific detail about all the various benefits…
Dec 20, 2024
A look at geographic atrophy in 2024: The highs, lows of treatment trials
By: Kate Young-Fact checked by: Heather Biele In 2024, Healio covered several stories about trials investigating geographic atrophy biomarkers and treatment options. While one trial found that intravitreal pegcetacoplan showed…
Dec 17, 2024
The Macular Degeneration Association Welcomes New Medical Board Member
The Macular Degeneration Association (MDA) is proud to welcome Jessica Cameron, OD, FAAO as one of our distinguished Medical Board members. Dr. Cameron is a low vision specialist. She owns…
Dec 17, 2024
Press Release – EYLEA HD Phase 3 Trial results (QUASAR trial)
Eylea HD injection of 8 gm in the Phase 3 trial (QUASAR trial) is meeting the primary endpoints showing improved vision with extended dosing intervals in patients with macular…
Dec 16, 2024
Galimedix Therapeutics initiates phase 1 trial of oral GAL-101
Author(s): David Hutton Key Takeaways GAL-101 targets misfolded amyloid beta monomers, preventing toxic oligomer and protofibril formation, with potential applications in Alzheimer’s, dry AMD, and glaucoma. The Phase 1 trial…
Dec 12, 2024
Exclusive 20% Off on Your Eye Care Essentials!
As part of our ongoing commitment to your eye health, we wanted to alert you about our partnership with DryEye Rescue, a trusted provider of specialized eye care products.…
Dec 10, 2024
‘Not all chocolate is created equal’: New data imply the dark variety lowers diabetes risk
By: Andrew (Drew) Rhoades Fact checked by: Gina Brockenbrough, MA Key takeaways: Eating 5 ounces or more of chocolate a week lowered type 2 diabetes risk. Results showed no link…
Dec 10, 2024
ARCHER trial shows benefit of ANX007 on vision loss in geographic atrophy
By: Michela Cimberle Fact checked by Christine Klimanskis, ELS BARCELONA, Spain — In the phase 2 ARCHER trial, ANX007, a novel C1q inhibitor with neuroprotective properties, showed consistent protection against loss of…
Dec 9, 2024
Is Nutrition The Culprit? With Dr. Poteet
A new video discusses nutrition and its affects on our bodies and our eyes. Did you know your nutrition can impact your risk of disease? Dr. Julie Poteet is a…
Dec 3, 2024
Sun Pharma announces positive Phase 4 data results in dry eye disease
Author(s): David Hutton Key Takeaways Cyclosporine ophthalmic solution 0.09% significantly improves dry eye disease symptoms in patients inadequately controlled on Restasis. The Phase 4 study showed sustained improvements in corneal…
Nov 27, 2024
Happy Thanksgiving
Happy Thanksgiving from our families to yours. We are grateful for your support and friendship. We will be closed on Thursday & Friday in observance of the Holiday.
Nov 22, 2024
Adverum reports positive 52-week, 4-year data for wet AMD gene therapy
by: Alex Young & Anthony DeFino Adverum Biotechnologies reported positive 52-week data from the phase 2 LUNA trial as well as long-term follow-up results from the OPTIC trial of Ixo-vec…
Nov 22, 2024
Early positive data reported for geographic atrophy modifier gene therapy
Key takeaways: Low-dose OCU410 slowed lesion growth, preserved retinal tissue, and stabilized visual function in three patients. No drug-related serious adverse events were reported. OCU410, a single-dose modifier gene therapy,…
Nov 18, 2024
Understanding blue light: Making sense of the spectrum
By Thomas A. Wong, OD, FAAO, FNAP & Karl Citek, OD, PhD, FAAO A new classification system helps patients reach informed decisions.
Nov 18, 2024
4 favorite foods with the most toxic plasticizers
By Anastasia Climan, RDN, CD-N | Fact-checked by Barbara Bekiesz | Published November 15, 2024 Key Takeaways The use of phthalates in food processing and packaging has led to widespread daily exposure, often in foods that are marketed…
Nov 12, 2024
Pistachios take over carrots as ultimate weapon for better, sharper vision?
Scientists have found nutty substitute for people seeking to improve eye health but dislike carrot by: Web Desk November 11, 2024 Carrots are often hailed as a superfood for eye…
Nov 8, 2024
FDA grants de novo authorization to photobiomodulation device for dry AMD
Key takeaways: The light delivery system maintained vision in a trial among patients with dry age-related macular degeneration. It is the first authorized treatment for vision loss related to dry…
Nov 7, 2024
Dropless cataract surgery: Shifting paradigm in postoperative care
Author(s): Monique M. Barbour, MD, Bria George, PharmD Key Takeaways Dropless cataract surgery eliminates postoperative eye drops, enhancing patient adherence and reducing complications like infection and inflammation. Intracameral drug delivery…
Nov 7, 2024
FDA clears investigational new drug application for wet AMD gene therapy
The FDA granted investigational drug clearance to HG202, a CRISPR/Cas13Y RNA-editing therapy for neovascular age-related macular degeneration, according to a press release from HuidaGene. According to the release, HG202 is the…
Nov 6, 2024
Intense pulsed light for treatment of dry eye disease
Author(s): David Hutton Joanne F. Shen, MD, director of the dry eye clinic at Mayo Clinic’s campus in Phoenix, Arizona, and a research team studied 35 patients treated with IPL/MGX.…
Nov 4, 2024
UV protection for the eyes: What patients need to know
October 29, 2024, By Cristina M. Schnider, OD, MSc, MBA, FAAO Many people know that invisible UV light can cause a sunburn and contribute to skin aging and skin cancer, but…
Oct 29, 2024
Daily consumption of pistachios boosts macular pigment optical density in healthy adults
October 28, 2024 Key takeaways: Eating 2 oz. of pistachios daily for 12 weeks significantly increased macular pigment optical density. Serum lutein concentration also improved in the group that consumed…
Oct 28, 2024
Genetic Links Explored: How inherited retinal dystrophies affect refractive errors in patients
Specific genes associated with inherited retinal dystrophies (IRDs) also influence refractive errors (RE), such as myopia and hyperopia, according to a study that found these genetic patterns vary widely, suggesting…
Oct 28, 2024
Alkeus Pharmaceuticals announces topline results from SAGA trial on GA treatment
October 25, 2024 ew study about Geographic Atrophy By Jordana Joy, Associate Editor The data showed a 15.3% reduction in the GA lesion growth rate versus placebo from 6 to 24…
Oct 23, 2024
#GIVING TUESDAY 2024
SAVE THE DATE: Tuesday December 3rd, 2024 #GivingTuesday—a movement to create a global day of giving Today. We need your help to help those Living with Macular Degeneration On Tuesday,…
Oct 22, 2024
Light therapy: Potential treatment for dry AMD
by: Lynda Charters Listen Key Takeaways Photobiomodulation may reduce visual loss and disease progression in dry AMD, offering a new treatment option for patients. The study showed significant visual acuity…
Oct 7, 2024
Metformin Shows Promise for Treating Macular Degeneration in Mice
A new study shows metformin may help prevent vision loss associated with age-related macular degeneration. News Published: October 7, 2024 Original story from the University of Chicago Age-related macular degeneration…
Sep 23, 2024
Alkeus Pharmaceuticals announces results from the SAGA study of oral gildeuretinol in patients with GA
September 19, 2024 By David Hutton Oral gildeuretinol demonstrated a clinically meaningful reduction in the geographic atrophy lesion growth rate at 24 months, supporting additional clinical development. SAGA topline data has…